|
| | Hyptadienic acid Basic information |
| Product Name: | Hyptadienic acid | | Synonyms: | Hyptadienic acid;Benzo[3,4]-18-norandrosta-3,5,15-triene-3(2'H)-carboxylicacid,3',4',5',6'-tetrahydro-3'-hydroxy-15-(hydroxymethyl)-3',4',9,14,17,17-hexamethyl-,(3b,3'a,4b,4'a,8a,9b,10a,13a,14b)-;Benzo[3,4]-18-norandrosta-3,5,15-triene-3(2'H)-carboxylic acid, 3',4',5',6'-tetrahydro-3'-hydroxy-15-(hydroxymethyl)-3',4',9,14,17,17-hexamethyl-, (3β,3'α,4β,4'α,8α,9β,10α,13α,14β)- | | CAS: | 128397-09-1 | | MF: | C30H46O4 | | MW: | 470.68 | | EINECS: | | | Product Categories: | | | Mol File: | 128397-09-1.mol |  |
| | Hyptadienic acid Chemical Properties |
| Melting point | 208-210 °C | | Boiling point | 590.6±50.0 °C(Predicted) | | density | 1.16±0.1 g/cm3(Predicted) | | solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | | form | Powder | | pka | 4.48±0.70(Predicted) |
| | Hyptadienic acid Usage And Synthesis |
| Description | Hyptadienic acid exhibits moderate cytotoxicity against HepG2 cells.
Hyptadienic acid shows a marked anti-inflammatory effect, it also exhibits strong antitumor-promoting activity in an in vivo two-stage carcinogenesis test of mouse tumor by using 7,12-dimethylbenz(a)anthracene (DMBA) as an initiator and TPA as a promoter. | | target | Immunology & Inflammation related |
| | Hyptadienic acid Preparation Products And Raw materials |
|
